Skip to main navigation menu Skip to main content Skip to site footer

Artigo Original

Vol. 5 No. 1 (2024)

Comparative analysis between pre- and post-operative histopathological findings of prostate adenocarcinoma in patients undergoing radical prostatectomy at the General Hospital of Fortaleza

DOI
https://doi.org/10.54257/2965-0585.v5.i1.99
Submitted
July 9, 2026
Published
2026-09-17

Abstract

Prostate cancer (PCa) is the most common malignancy in men. The worsening of cellular undifferentiation, i.e., Gleason score (‘upgrade’) and clinical staging (‘upstage’) when comparing pre- and postoperative histopathological findings is well described in the literature. The objective of this study was to evaluate the histopathological results of prostate biopsies by transrectal ultrasound and surgical specimens from radical prostatectomy, from October 2022 to July 2024, at the Urology service of the General Hospital of Fortaleza. Preoperative factors such as serum PSA, transrectal ultrasound biopsy, and digital rectal examination were evaluated. Furthermore, histopathological parameters of the specimen were assessed, and it was observed that extraprostatic extension and focally affected margins were related to ‘upstage’. These data are insufficient to predict these conditions; therefore, new tools are needed to ensure better counseling for optimal treatment planning.

References

  1. INCA. Estimativa 2023: Incidência decâncernoBrasil.InstitutoNacionaldeCâncer; 2023.Disponívelem:https://www.inca.gov.br.Acessoem:20ago.2024.
  2. INCA. Manual de Diagnóstico e TratamentodoCâncerdePróstata.InstitutoNacional de Câncer; 2020. Disponível em: https://www.inca.gov.br/manual-de-diagnostico-e-tratamento-do-cancer-de-prostata.Acesso em: 20 ago. 2024.
  3. SilvaAC,AlmeidaFA.EpidemiologiadocâncerdepróstatanoBrasil:umarevisão.Rev Bras Oncol. 2022;68(1):23-31.
  4. Taggart R, Dutto L, Leung HY, Salji M, Ahmad I.Acontemporaryanalysisofdisease upstaging of Gleason 3+3 prostate cancer patients after robot-assisted laparoscopic prostatectomy. Cancer Med. 2023 Nov;12(22):20830-7. doi: 10.1002/cam4.6651. Epub 2023Nov6.PMID:37929881;PMCID:PMC10709727. DOI: https://doi.org/10.1002/cam4.6651
  5. Leeman JE, Chen MH, Huland H, GraefenM,D'AmicoAV,TilkiD.Advancingageand theoddsofupgradingandupstagingatradicalprostatectomyinmenwithGleasonscore 6 prostate cancer. Clin Genitourin Cancer. 2019 Dec;17(6):e1116-e1121. doi: 10.1016/j.clgc.2019.07.018. Epub 2019 Aug 5. PMID: 31601512. DOI: https://doi.org/10.1016/j.clgc.2019.07.018
  6. D'Elia C, Cerruto MA, Cioffi A, Novella G, Cavalleri S, Artibani W. Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy. Mol Clin Oncol. 2014 Nov;2(6):1145-9. doi: 10.3892/mco.2014.370. Epub 2014 Aug 5. PMID: 25279213; PMCID: PMC4179778. DOI: https://doi.org/10.3892/mco.2014.370
  7. Braeckman J, Michielsen D. Prognostic factors in prostate cancer. Recent Results Cancer Res. 2007;175:25-32. doi: 10.1007/978-3-540-40901-4_3. PMID: 17432552. DOI: https://doi.org/10.1007/978-3-540-40901-4_3
  8. Ministério da Saúde. Câncer de próstata: Diretrizes e recomendações. Brasília: Ministério da Saúde; 2022.Disponívelem:https://www.gov.br/saude/pt-br.Acessoem: 20 ago. 2024.
  9. Flammia RS, Hoeh B, Hohenhorst L, Sorce G, ChierigoF,PanunzioA,TianZ,SaadF, LeonardoC,BrigantiA,AntonelliA,TerroneC,ShariatSF,AnceschiU,GraefenM,Chun FKH, Montorsi F, Gallucci M, Karakiewicz PI. Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients.IntUrolNephrol.2022;54(10):2521-8. doi: 10.1007/s11255-022-03250-0. Epub 15 jul. 2022. PMID: 35838831; PMCID: PMC9463257. DOI: https://doi.org/10.1007/s11255-022-03250-0
  10. CapitanioU,KarakiewiczPI,ValiquetteL,etal.Biopsycorenumberrepresentsoneof foremost predictors of clinically significant Gleason sum upgrading in patients with low-riskprostatecancer.Urology.2009;73:1087-91. DOI: https://doi.org/10.1016/j.urology.2008.10.048
  11. Epstein JI, Feng Z, Trock BJ, Pierorazio PM.Upgradinganddowngradingofprostate cancerfrombiopsytoradicalprostatectomy:incidenceandpredictivefactorsusingthe modified Gleason grading system and factoring in tertiary grades. Eur Urol. 2012;61:1019-24. DOI: https://doi.org/10.1016/j.eururo.2012.01.050
  12. Epstein JI, Allsbrook WC Jr, et al.ISUPGradingCommittee.The2005International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228-42. DOI: https://doi.org/10.1097/01.pas.0000173646.99337.b1
  13. Serkin FB, Soderdahl DW, Cullen J, et al. Patient risk stratification using Gleason scoreconcordanceandupgradingamongmenwithprostatebiopsyGleasonscore6 or
  14. UrolOncol.2010;28:302-7. DOI: https://doi.org/10.1038/scientificamerican0310-28

Most read articles by the same author(s)